Published in Lancet on January 19, 2010
Treatment of bipolar disorder. Lancet (2013) 2.93
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
A safe lithium mimetic for bipolar disorder. Nat Commun (2013) 1.51
Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry (2016) 1.38
Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans. Neuropsychopharmacology (2015) 1.11
Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS One (2011) 1.10
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology (2011) 1.08
Positive Imagery-Based Cognitive Bias Modification as a Web-Based Treatment Tool for Depressed Adults: A Randomized Controlled Trial. Clin Psychol Sci (2015) 1.07
Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord (2014) 1.07
Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery. Behav Res Ther (2011) 1.07
A decision analysis of long-term lithium treatment and the risk of renal failure. Acta Psychiatr Scand (2012) 1.05
Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One (2014) 0.97
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2016) 0.96
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. Clin Trials (2011) 0.87
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS Med (2011) 0.86
Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. World Psychiatry (2016) 0.85
The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. Int J Bipolar Disord (2015) 0.85
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders. Pharmacotherapy (2011) 0.84
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials (2013) 0.84
Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways. J Clin Neurol (2010) 0.84
Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Bipolar Disord (2012) 0.83
Lithium: the pharmacodynamic actions of the amazing ion. Ther Adv Psychopharmacol (2013) 0.83
Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability. J Neurochem (2012) 0.83
Bipolar depression: clinically missed, pharmacologically mismanaged. Ther Adv Psychopharmacol (2011) 0.83
Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. Transl Psychiatry (2016) 0.82
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82
Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients. Int J Bipolar Disord (2013) 0.82
Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am Health Drug Benefits (2014) 0.81
Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci (2016) 0.80
A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord (2015) 0.80
Label-free, live optical imaging of reprogrammed bipolar disorder patient-derived cells reveals a functional correlate of lithium responsiveness. Transl Psychiatry (2014) 0.79
Asenapine in the treatment of older adults with bipolar disorder. Int J Geriatr Psychiatry (2014) 0.79
Mood disorders in the elderly: prevalence, functional impact, and management challenges. Neuropsychiatr Dis Treat (2016) 0.79
Genomics of Lithium Action and Response. Neurotherapeutics (2017) 0.79
Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study. Neuropsychopharmacology (2015) 0.78
Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla. Psychopharmacology (Berl) (2016) 0.78
Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder. Biochim Biophys Acta (2013) 0.78
Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: three case histories. Ther Adv Psychopharmacol (2014) 0.78
The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry (2016) 0.78
Practical clinical trials in psychopharmacology: a systematic review. J Clin Psychopharmacol (2015) 0.77
Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Psychopharmacol Bull (2010) 0.77
The presentation, recognition and management of bipolar depression in primary care. J Gen Intern Med (2013) 0.76
Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania. Int J Bipolar Disord (2015) 0.76
The BALANCE trial. Lancet (2010) 0.76
Asenapine for bipolar disorder. Neuropsychiatr Dis Treat (2015) 0.76
Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Bipolar Disord (2015) 0.76
Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid. J Neural Transm (Vienna) (2012) 0.75
Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? Ann Gen Psychiatry (2011) 0.75
A new BALANCE in bipolar I disorder. Lancet (2010) 0.75
Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations. Drugs R D (2016) 0.75
Prophylaxis and treatment of bipolar disorder in older adults. J Psychiatry Neurosci (2012) 0.75
Is Valproate Depressogenic in Patients Remitting from Acute Mania? Case Series. Case Rep Psychiatry (2015) 0.75
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder. Hum Genomics Proteomics (2010) 0.75
Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study. BMC Psychiatry (2014) 0.75
The BALANCE trial. Lancet (2010) 0.75
Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients. Clin Pract Epidemiol Ment Health (2016) 0.75
Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. J Am Assoc Nurse Pract (2015) 0.75
Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder? Int J Bipolar Disord (2013) 0.75
Can Antipsychotic Agents be Considered as Real Antimanic Treatments? Front Psychiatry (2014) 0.75
GADL1 variant and medication adherence in predicting response to lithium maintenance treatment in bipolar I disorder. BJPsych Open (2016) 0.75
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. Neuropsychiatr Dis Treat (2015) 0.75
Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing. Psychopharmacology (Berl) (2016) 0.75
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? Clin Drug Investig (2017) 0.75
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (2009) 14.52
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet (2011) 6.11
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet (2003) 5.75
Lithium toxicity profile: a systematic review and meta-analysis. Lancet (2012) 4.82
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry (2004) 4.72
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry (2006) 4.30
Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry (2006) 4.19
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ (2011) 3.74
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ (2006) 3.69
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66
Depression and violence: a Swedish population study. Lancet Psychiatry (2015) 3.44
Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol (2006) 3.30
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry (2004) 3.23
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ (2013) 3.08
Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry (2009) 3.04
Suicide, depression, and antidepressants. BMJ (2005) 2.88
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med (2009) 2.80
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Schizophrenia and violence: systematic review and meta-analysis. PLoS Med (2009) 2.74
Sustained attention deficit in bipolar disorder. Br J Psychiatry (2002) 2.66
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry (2005) 2.64
Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry (2011) 2.47
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry (2010) 2.31
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry (2004) 2.31
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry (2006) 2.30
Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. Br J Psychiatry (2006) 2.28
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ (2009) 2.25
Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry (2015) 2.15
Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry (2005) 2.13
Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry (2014) 2.11
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry (2011) 2.10
Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect Immun (2009) 2.08
Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry (2009) 1.99
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry (2005) 1.97
Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry (2008) 1.96
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry (2011) 1.89
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord (2008) 1.84
Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care (2010) 1.82
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry (2013) 1.80
Peering through the barriers in GPs' explanations for declining to participate in research: the role of professional autonomy and the economy of time. Fam Pract (2007) 1.79
EMA must improve the quality of its clinical trial reports. BMJ (2011) 1.78
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry (2004) 1.74
Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry (2005) 1.73
Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull (2008) 1.70
Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry (2009) 1.70
Gastrostomy tube feeding in children with cerebral palsy: a prospective, longitudinal study. Dev Med Child Neurol (2005) 1.64
Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry (2011) 1.63
The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord (2010) 1.61
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry (2009) 1.59
Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry (2009) 1.59
Psychiatric assessment of mood instability: qualitative study of patient experience. Br J Psychiatry (2013) 1.58
Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev (2015) 1.58
Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry (2007) 1.57
Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev (2014) 1.56
Meta-analysis of brain weight in schizophrenia. Schizophr Res (2003) 1.54
What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med (2008) 1.54
Mental imagery as an emotional amplifier: application to bipolar disorder. Behav Res Ther (2008) 1.53
Gastrostomy feeding in cerebral palsy: too much of a good thing? Dev Med Child Neurol (2006) 1.51
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness. Biol Psychiatry (2010) 1.47
Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry (2008) 1.47
Gastrostomy feeding in cerebral palsy: enough and no more. Dev Med Child Neurol (2010) 1.40
Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med (2005) 1.37
Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol (2005) 1.30
Patients' views and readmissions 1 year after involuntary hospitalisation. Br J Psychiatry (2009) 1.29
Why do general practitioners decline training to improve management of medically unexplained symptoms? J Gen Intern Med (2007) 1.29
Selective serotonin reuptake inhibitors. BMJ (2004) 1.28
Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial. PLoS Med (2009) 1.28
Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry (2005) 1.28
Research into practice: Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Nottinghamshire, Derbyshire, Lincolnshire (NDL). Implement Sci (2012) 1.26
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry (2006) 1.24
Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry (2005) 1.23
The cognitive neuropsychology of depression in the elderly. Psychol Med (2007) 1.22
Long-term treatment of depression with antidepressants: a systematic narrative review. Can J Psychiatry (2007) 1.20
Venlafaxine for major depression. BMJ (2007) 1.20